Clinical manifestations, hormonal profile and rationale of the polycystic ovary syndrome and infertility in Pakistani women

https://doi.org/10.53730/ijhs.v6nS10.14088

Authors

  • Monika Woman Medical Officer, Population Welfare Department, Larkana Pakistan
  • Naushabah Malik Specialist Trainee, West Midlands UK
  • Mehwish Waqar Woman Medical Officer, Pak Red Crescent Teaching Hospital, Dina Nath Kasur Pakistan
  • Nadeem Naeem Consultant Endocrinologist and Physician, MMIH, Karachi Pakistan
  • Erum Memon Jinnah Medical and Dental College, Karachi Pakistan
  • Hafiza Yasmeen Abbas MBBS, FCPS, Specialist in OBG. Alkiyumi Medical Complex, Oman

Keywords:

anovulation, endometrial cancer, female infertility, hyperandrogenism

Abstract

Introduction: Many women of reproductive age experience polycystic ovary syndrome (PCOS), characterized by growth of cysts on the ovaries that range in size from 2 to 10mm in antral measurement, oligomenorrhea, menorrhagia, acne and hyperandrogenism. Objective: The study aimed to correlate the rational of PCOS with infertility in women. Place and Duration: The study was conducted in different districts of Sindh in Pakistan during the period 2020-22. Methods: This cross-sectional study aimed to determine how common infertility was among women with PCOS who sought care at different gynecological clinics. Pathological investigation of the patient's hormonal profile, including serum insulin, serum prolactin, LH, FSH, and serum testosterone levels were also investigated. Results: 316 of infertile women (63.20%) were diagnosed with PCOS. Females had oligomenorrhea as the predominant (p<0.05) pattern of the PCOS-affected females. Acne, hirsutism, and hyperandrogenism were significantly (P<0.05) more common among these women. In women with PCOS, the level of testosterone was significantly elevated (132+2.39 ng/dl; P<0.05). Conclusion: PCOS is the leading cause of infertility owing to anovulation, as affected women displayed severe clinical manifestations of oligomenorrhea, hirsutism, acne, hyperandrogenism, and elevated testosterone levels and thus can easily be diagnosed and treated accordingly.

Downloads

Download data is not yet available.

References

Collee J, Mawet M, Tebache L, Nisolle M and Brichant G. Review: Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecological Endocrinology. 2021;37(10): 869–874.

Rotterdam Eshre/ASRM-Sponsored PCOS consensus Workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction. 2004;19:41–7.

Mirza FG, Tahlak MA, Rjeili RB, Hazari K, Ennab F, Hodgman C, Khamis AH and Atiomo W. Polycystic ovarian syndrome (PCOS): Does the challenge end at conception? International Journal of Envrionmental Research and Public Health. 2022;19(22): 14914.

Cunha A and Povoa AM. Infertility management in women with polycystic ovary syndrome: a review. Porto Biomedical Journal. 2021;26:6(1):e116.

Yousaf J, Khadija S, Arshad N, Amjad MR, Gulzar J and Ullah S. The Chances of Infertility in a Patient Presenting with PCOS in Childbearing Age, Review Article. Saudi Journal of Medicine. 2022;7(1):15-21.

Memon TF, Meghji KA, Rajar AB, Khowaja S, Azam A and Khatoon S. Clinical, hormonal and metabolic factors associated with polycystic ovary syndrome among Pakistani women. Rawal Medical Journal. 2020;45(4):817-821.

Saadia Z. 2020. Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women. Medical Archives. 2020;74(4):289-293.

Declaration of Helsinki. In clinical research Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964.

Deswal R, Narwal V, Dang A and Pundir CS. The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. Journal of Human Reproductive Sciences. 2020;13(4):261-271.

Ganie MA, Marwaha RK, Aggarwal R and Singh S. High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: A case-control study. European Journal of Endocrinology. 2010;162:1117–22.

Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S and Vaidya R. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian Journal of Endocrinology and Metabolism. 2014;18:317–24.

Zandi S, Farajzadeh S and Safari H. Prevalence of polycystic ovary syndrome in women with acne: hormone profiles and clinical findings. Journal of Pakistan Association of Dermatologists. 2016;20:194-8.

Lentscher JA, Slocum B and Torrealday S. Polycystic ovarian syndrome and fertility. Clinical Obstetrics and Gynecology. 2020;64(1):65-75.

Oriji VK and Onwuegbulam C. Prevalence of Polycystic Ovary Syndrome (PCOS) among Infertile Women Attending Fertility Clinic at a University Teaching Hospital in Nigeria. Journal of Gynecology and Women’s Health. 2020;15(5):555922.

Obuna JA, Ndukwe EO, Ugboma HAA, Ejikeme BN, Ugboma EW. Clinical presentation of infertility in an outpatient clinic of a resource poor setting, South East Nigeria. International Journal of Tropical Disease and Health. 2012;2(2):123-131.

Hussein B and Alalaf S. prevalence and characteristics of polycystic ovary syndrome in a sample of infertile Kurdish women attending IVF infertility centre in Mternity Teaching Hospital of Erbil City. Open Journal of Obstetrics and Gynecology. 2013;3:577- 585.

Kristensen SL, Ramiau-Hansen CH, Ernst E, Olsen SF and Bonde JP. A very large population of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed? Hum Reproduction. 2010;25(12):3117-3122.

Kousta E, White DM, Cela E, McCarthy MI and Frank S. The prevalence of polycystic ovaries in women with infertility. Human Reproduction. 1999;14(11):2720-2723.

Martins WP, Kollmann M and Fenning NR. Counting ovarian follicles: updated threshold for diagnosis of hyperandrogenic anovulation. Ultrasound in Obstetrics and Gynecology. 2014;44(2):131-134.

Ndefo UA, Eaton A, Green MR. Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches. Physical Therapy. 2013;38(6):336-55.

Ashraf S, Nabi M, Rasool SA, Rashid F and Amin S. Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review. Egyptian Journal of Medical Human Genetics. 2019;20(25):1-10.

Akram M and Roohi N. Endocrine Correlates of Polycystic Ovary Syndrome in Pakistani Women. Journal of the College of Physicians and Surgeons Pakistan. 2015;25(1):22-26.

Frank G, Bizan A, Wloch S, Kowalczik K, Bartnik AB and Madej P. Hormonal and metabolic aspects of acne vulgaris in women with polycystic ovary syndrome. European Review for Medical and Pharmacological Sciences. 2018;22:4411-4448.

Khan TU, Memon NN, Riaz A, Khan ZH, Haroon SM and Khan KH. Serum free testosterone levels in polycystic ovarian syndrome patients and its correlation with clinical hyperandrogenism in Pakistan. Journal of Fatima Jinnah Medical University. 2020;14(3):132-135.

Zafar U, Memon Z, Moin K, Agha S, Hassan JA and Zehra D. Prevalence of PCOS with associated symptoms and complications at Tertiary Care Hospital of Karachi. Journal of Advanced Medicine and Medical Research. 2019;30:1-9.

Published

24-03-2023

How to Cite

Monika, Malik, N., Waqar, M., Naeem, N., Memon, E., & Abbas, H. Y. (2023). Clinical manifestations, hormonal profile and rationale of the polycystic ovary syndrome and infertility in Pakistani women. International Journal of Health Sciences, 6(S10), 1550–1558. https://doi.org/10.53730/ijhs.v6nS10.14088

Issue

Section

Peer Review Articles